<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="courier ; font-style : italic;} Infect Dis PovertyInfect Dis PovertyInfectious" exact="Diseases" post="of Poverty2095-51622049-9957BioMed CentralLondon pmcid: 7247188668 doi: 10.1186/s40249-020-00668-5 : Research"/>
 <result pre="China, 2017 KangRui-Hua1LiangShu-Jia2MaYan-Ling3LiangShu4XiaoLin5ZhangXin-Hui6LuHong-Yan7XuXiao-Qin8LuoShui-Bin9SunXiao-Guang10ChenLin11HeJian-Mei12WuGuo-Hui13LiaoLing-Jie12XingHui12ShaoYi-Mingyshao@bjmu.edu.cn12RuanYu-Huaruanyuhua92@163.com1[1], grid.198530.60000 0000 8803 2373State Key Laboratory of" exact="Infectious" post="Disease Prevention and Control (SKLID), National Center for AIDS/STD"/>
 <result pre="2017 KangRui-Hua1LiangShu-Jia2MaYan-Ling3LiangShu4XiaoLin5ZhangXin-Hui6LuHong-Yan7XuXiao-Qin8LuoShui-Bin9SunXiao-Guang10ChenLin11HeJian-Mei12WuGuo-Hui13LiaoLing-Jie12XingHui12ShaoYi-Mingyshao@bjmu.edu.cn12RuanYu-Huaruanyuhua92@163.com1[1], grid.198530.60000 0000 8803 2373State Key Laboratory of Infectious" exact="Disease" post="Prevention and Control (SKLID), National Center for AIDS/STD Control"/>
 <result pre="Center for AIDS/STD Control and Prevention (NCAIDS), Chinese Center for" exact="Disease" post="Control and Prevention (China CDC), Collaborative Innovation Center for"/>
 <result pre="(China CDC), Collaborative Innovation Center for Diagnosis and Treatment of" exact="Infectious" post="Diseases, [2], grid.198530.60000 0000 8803 2373Guangxi Center for Disease"/>
 <result pre="of Infectious Diseases, [2], grid.198530.60000 0000 8803 2373Guangxi Center for" exact="Disease" post="Control and Prevention, [3], [4], grid.198530.60000 0000 8803 2373Sichuan"/>
 <result pre="and Prevention, [3], [4], grid.198530.60000 0000 8803 2373Sichuan Center for" exact="Disease" post="Control and Prevention, [5], [6], grid.496805.6Guizhou Center for Disease"/>
 <result pre="for Disease Control and Prevention, [5], [6], grid.496805.6Guizhou Center for" exact="Disease" post="Control and Prevention, [7], grid.198530.60000 0000 8803 2373Beijing Center"/>
 <result pre="Control and Prevention, [7], grid.198530.60000 0000 8803 2373Beijing Center for" exact="Disease" post="Control and Prevention, [8], [9], [10], grid.198530.60000 0000 8803"/>
 <result pre="Prevention, [8], [9], [10], grid.198530.60000 0000 8803 2373Shandong Center for" exact="Disease" post="Control and Prevention, [11], grid.464443.5Shenzhen Center for Disease Control"/>
 <result pre="Center for Disease Control and Prevention, [11], grid.464443.5Shenzhen Center for" exact="Disease" post="Control and Prevention, [12], [13], epub: 2020-5-5pmc-release: 2020-5-5collection: 2020954received:"/>
 <result pre="was evaluated in adults initiating antiretroviral therapy in China. Methods" exact="Blood" post="samples were obtained from 1943 patients who initiated antiretroviral"/>
 <result pre="nationwide scale in 2003 [14] and all individuals with HIV" exact="infections" post="who provide consent can currently be treated [15]. However,"/>
 <result pre="four municipalities, five autonomous regions, and two special administrative regions." exact="HIV infection" post="was originally identified among injected drug users (IDUs) in"/>
 <result pre="municipalities, five autonomous regions, and two special administrative regions. HIV" exact="infection" post="was originally identified among injected drug users (IDUs) in"/>
 <result pre="populations in China. According to the numbers of newly reported" exact="HIV/AIDS" post="in the year 2016 in China [19], the high"/>
 <result pre="who were under 18 years old, or those who may be" exact="acquired" post="drug resistance from previous antiretroviral drug exposure (such as"/>
 <result pre="first-line ART after a period of treatment interruption without documented" exact="viral" post="failure or among people who have received pre-exposure prophylaxis"/>
 <result pre="sex, marital status, ethnicity, years of education and route of" exact="HIV infection" post="were achieved from the national epidemiology database of HIV"/>
 <result pre="marital status, ethnicity, years of education and route of HIV" exact="infection" post="were achieved from the national epidemiology database of HIV"/>
 <result pre="HIV infection were achieved from the national epidemiology database of" exact="HIV infection" post="[21]. History of ART drug use was asked by"/>
 <result pre="infection were achieved from the national epidemiology database of HIV" exact="infection" post="[21]. History of ART drug use was asked by"/>
 <result pre="by the doctor and validated by the NFATP database of" exact="HIV infection" post="[22]. To avoid the patients with a history of"/>
 <result pre="the doctor and validated by the NFATP database of HIV" exact="infection" post="[22]. To avoid the patients with a history of"/>
 <result pre="was evaluated using the algorithm of the Stanford HIV Drug" exact="Resistance" post="Database (HIVDB) (https://hivdb.stanford.edu/hivdb/by-sequences/). Identification of genetic transmission networks To"/>
 <result pre="packages in R 3.5.0 software (the Free Software Foundation’s GNU" exact="General" post="Public License, Auckland, New Zealand) were used [28]. Statistical"/>
 <result pre="using SAS V9.4 (SAS Institute Inc., Cary, NC, USA). Results" exact="General" post="characteristics of the study population During the study period,"/>
 <result pre="population During the study period, we recruited 1943 participants in" exact="total" post="and acquired 1731 (89.1%) sequences. Twenty participants were excluded,"/>
 <result pre="the study period, we recruited 1943 participants in total and" exact="acquired" post="1731 (89.1%) sequences. Twenty participants were excluded, including fourteen"/>
 <result pre="initiating ART in 2017 in China Variable Number Percentage (%)" exact="Total" post="1711 100.0 Age (years)   &amp;lt; 25 209 12.2   ≥ 25 1502"/>
 <result pre="217 12.7  College 307 17.9  Unknown 53 3.1 Route of" exact="infection" post=" Heterosexual intercourse 1027 60.0  Homosexual intercourse 453 26.5  Intravenous"/>
 <result pre="53 3.1  Others 134 7.8 Pretreatment HIV drug resistance In" exact="total" post="6.8% (117/1711) of patients had PDR. Among them, 79"/>
 <result pre="drug resistance N (%) HIV drug resistance mutations, N (%)" exact="Total" post="117 (6.8) Non-nucleoside reverse transcriptase inhibitors (NNRTIs, any) 79"/>
 <result pre="(0.06) a National free antiviral drugs in China HIV Human" exact="immunodeficiency" post="virus, NNRTI Non-nucleoside reverse transcriptase inhibitor, NRTI nucleoside reverse"/>
 <result pre="Number of PDR Prevalence (%) Prevalence (%) NNRTIs NRTIs PIs" exact="Total" post="1711 117 6.8 4.6(79/1711) 2.2 (38/1711) 0.6 (10/1711) High"/>
 <result pre="N (%) OR (95% CI) P-value aOR (95% CI) P-value" exact="Total" post="1711 117 (6.8) Age (years)   &amp;lt; 25 209 16 (7.7)"/>
 <result pre="0.07  Unknown 53 1 (1.9) 0.22 (0.03–1.60) 0.13 Route of" exact="infection" post=" Heterosexual intercourse 1027 57 (5.6) 1.00 1.00  Homosexual intercourse"/>
 <result pre="odds ratio, CI confidence interval, ART antiretroviral therapy, HIV Human" exact="immunodeficiency" post="virus, HIVDR HIV drug resistance; -: Not applicable. Genetic"/>
 <result pre="as Zimbabwe (6.3%) [29] and Sub-Saharan Africa (5.5%) [30] but" exact="lower" post="than estimates for Kenya (9.4%) [27], Argentina (14.0%) [31],"/>
 <result pre="HIV epidemics and IDUs are the main high-risk population for" exact="HIV infection." post="Antiretroviral treatment was initiated early and the highest rates"/>
 <result pre="suggest that PDR could be transmitted among high-risk populations for" exact="HIV infection" post="in the future. The study had the following limitations."/>
 <result pre="that PDR could be transmitted among high-risk populations for HIV" exact="infection" post="in the future. The study had the following limitations."/>
 <result pre="effectiveness of current ART regimens in China. Abbreviations HIV Human" exact="immunodeficiency" post="virus PDR Pretreatment drug resistance PLWHA People living with"/>
 <result pre="living with HIV or AIDS UNAIDS United Nations programme on" exact="HIV/AIDS" post="WHO World Health Organization ART Antiretroviral therapy ARV Antiretroviral"/>
 <result pre="Lopinavir ATV/r Atazanavir DRM Drug resistance mutation HIVDR HIV Drug" exact="Resistance" post="Database TN93 Tamura–Nei 93 OR Odds ratio aOR Adjusted"/>
 <result pre="Shenzhen, Guangxi, Neijiang, Liangshan, Chongqing, Guizhou, and Yunnan Center for" exact="Disease" post="Control and Prevention. Authors’ contributions RK, LL, HX, YS"/>
 <result pre="Guangxi Bagui Honor Scholarship, and Chinese State Key Laboratory of" exact="Infectious" post="Disease Prevention and Control. Availability of data and materials"/>
 <result pre="Bagui Honor Scholarship, and Chinese State Key Laboratory of Infectious" exact="Disease" post="Prevention and Control. Availability of data and materials The"/>
 <result pre="Center for AIDS/STD Control and Prevention (NCAIDS), Chinese Center for" exact="Disease" post="Control and Prevention (China CDC). Consent for publication Not"/>
 <result pre="nurse-managed, community cohort in LesothoAIDS.201024172645265020980868 3.JohnsonLFMossongJDorringtonRESchomakerMHoffmannCJKeiserOet al.Life expectancies of south" exact="African" post="adults starting antiretroviral treatment: collaborative analysis of cohort studiesPLoS"/>
 <result pre="on the use of antiretroviral drugs for treating and preventing" exact="HIV infection." post="WHO2016 14.ZhangFHabererJEWangYZhaoYMaYZhaoDet al.The Chinese free antiretroviral treatment program: challenges"/>
 <result pre="near full-length genome analysesAIDS.201226787788422269972 18.PiyasirisilpSMcCutchanFECarrJKSanders-BuellELiuWChenJet al.A recent outbreak of human" exact="immunodeficiency" post="virus type 1 infection in southern China was initiated"/>
 <result pre="genome analysesAIDS.201226787788422269972 18.PiyasirisilpSMcCutchanFECarrJKSanders-BuellELiuWChenJet al.A recent outbreak of human immunodeficiency virus" exact="type 1" post="infection in southern China was initiated by two highly"/>
 <result pre="18.PiyasirisilpSMcCutchanFECarrJKSanders-BuellELiuWChenJet al.A recent outbreak of human immunodeficiency virus type 1" exact="infection" post="in southern China was initiated by two highly homogeneous,"/>
 <result pre="2015 WHO surveyLancet HIV2016312e579e59127658867 33.collab: Title of subordinate documentHIV Drug" exact="Resistance" post="Report 2017. WHO2017 34.SilvermanRABeckIAKiptinnessCLevineMMilneRMcGrathCJet al.Prevalence of pre-antiretroviral-treatment drug resistance"/>
</results>
